Eric Benevich
2019
Compensation breakdown
| Bonus | $280,320 |
|---|---|
| Option Awards | $3,750,345 |
| Salary | $467,200 |
| Stock Awards | $1,250,035 |
| Other | $45,547 |
| Total | $5,793,447 |
Benevich received $3.8M in option awards, accounting for 65% of the total pay in 2019.
Benevich also received $280.3K in bonus, $467.2K in salary, $1.3M in stock awards and $45.5K in other compensation.
Rankings
In 2019, Eric Benevich's compensation ranked 1,808th out of 13,971 executives tracked by ExecPay. In other words, Benevich earned more than 87.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,808 out of 13,971 | 87th |
Division Manufacturing | 650 out of 5,701 | 89th |
Major group Chemicals And Allied Products | 199 out of 2,200 | 91st |
Industry group Drugs | 160 out of 1,886 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 38 out of 389 | 90th |
Pay ratio
| Eric Benevich's Pay | $5,793,447 |
|---|---|
| Median Employee's Pay | $257,209 |
| Pay Ratio | 23to 1 |
In 2019, the annual total compensation of Eric Benevich was $5,793,447.
The annual total compensation of the median employee at Neurocrine Biosciences was $257,209.
The ratio of Eric Benevich's pay to the pay of median employee was therefore 23 to one.
Benevich's colleagues
We found five more compensation records of executives who worked with Eric Benevich at Neurocrine Biosciences in 2019.
2019
Kevin Gorman
Neurocrine Biosciences
Chief Executive Officer
2019
Matthew Abernethy
Neurocrine Biosciences
Chief Financial Officer
2019
Eiry Roberts
Neurocrine Biosciences
Chief Medical Officer
2019
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
2019
Kyle Gano
Neurocrine Biosciences
Chief Development and Strategy Officer
News
April 7, 2022
April 9, 2021
April 9, 2020
April 17, 2019